赢8娱乐糖果配对游戏-官方网站[welcome]


+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Testicular Histology after Treatment with the new Antiandrogen Casodex for Carcinoma of the Prostate



Testicular Histology after Treatment with the new Antiandrogen Casodex for Carcinoma of the Prostate



Scandinavian Journal of Urology and Nephrology 28(1): 67-70




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068447623

Download citation: RISBibTeXText

DOI: 10.3109/00365599409180473


Related references

Testicular histology after treatment with the new antiandrogen Casodex for carcinoma of the prostate. A preliminary report. Scandinavian Journal of Urology and Nephrology 28(1): 67-70, 1994

Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176334) or bilateral orchidectomy. Urological Research 22(3): 191-195, 1994

Casodex (bicalutamide): overview of a new antiandrogen developed for the treatment of prostate cancer. European Urology 31(Suppl. 2): 30-39, 1997

Once daily treatment with the nonsteroidal antiandrogen casodex for advanced prostate cancer. Journal of Urology 143(4 Suppl.): 308A, 1990

Efficacy and safety of the nonsteroidal antiandrogen casodex in the treatment of advanced prostate cancer. Journal of Urology 141(4 Part 2): 346A, 1989

Clinical trials with the nonsteroidal antiandrogen casodex in the treatment of advanced prostate cancer. Cancer Investigation 9(3): 384, 1991

Feasibility study for the treatment of metastatic prostate cancer with the radioactive antiandrogen I-125-bicalutamide (=I-125-casodex). International Journal of Radiation Oncology*biology*physics 48(3-Supp-S1): 316-0, 2000

PSA response to secondary androgen deprivation following failed treatment of metastatic prostate cancer with the antiandrogen casodex. Urologic Oncology 1(2): 64-66, 1995

Casodex ici 176334 a new steroidal antiandrogen in prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 30: 311, 1989

Testicular histology after treatment with LH-RH analogue for carcinoma of the prostate. British Journal of Urology 65(4): 376-378, 1990

Antagonist/Agonist Balance of the Nonsteroidal Antiandrogen Bicalutamide (Casodex) in a New Prostate Cancer Model. Urologia Internationalis 65(2): 73-79, 2000

Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer model. Urologia Internationalis 65(2): 73-79, 2000

Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex. Journal of Molecular Endocrinology 24(3): 339-351, 2000

Randomised study of Casodex 50 MG monotherapy vs orchidectomy in the treatment of metastatic prostate cancer. The Scandinavian Casodex Cooperative Group. Scandinavian Journal of Urology and Nephrology 30(2): 93-98, 1996

Androgen Receptor Gene Amplificationin a Recurrent Prostate Cancer afterMonotherapy with the NonsteroidalPotent Antiandrogen Casodex(Bicalutamide) with a SubsequentFavorable Response to MaximalAndrogen Blockade. European Urology 31(2): 216-219, 1997





赢8娱乐糖果配对游戏